相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia
Angela M. Carneiro et al.
OPHTHALMOLOGICA (2011)
Intravitreal Ranibizumab for Choroidal Neovascularization in Angioid Streaks
Gerard Mimoun et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Improvement of Angiographic Findings of Polypoidal Choroidal Vasculopathy After Intravitreal Injection of Ranibizumab Monthly for 3 Months
Taiichi Hikichi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab
Alexandros N. Stangos et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
P. Mitchell et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results
Gregg T. Kokame et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab
Akitaka Tsujikawa et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2010)
Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients
Mihoko Suzuki et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2010)
Intravitreal ranibizumab (LucentisA®) for the treatment of myopic choroidal neovascularization
Lazaros Konstantinidis et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: A 30-month multicenter study in Hyogo, Japan
Shigeru Honda et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2009)
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown et al.
OPHTHALMOLOGY (2009)
INTRAVITREAL RANIBIZUMAB FOR THE PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA
Timothy Y. Y. Lai et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Ranibizumab for neovascular age-related macular degeneration
Luis Javier Hernandez-Pastor et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy
T. Y. Y. Lai et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration
Michael S. Ip et al.
OPHTHALMOLOGY (2008)
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients
Fumi Gomi et al.
OPHTHALMOLOGY (2008)
Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy
F. Gomi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Clinical characteristics of exudative age-related macular degeneration in Japanese patients
Ichiro Maruko et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Age-related macular degeneration and recent developments: new hope for old eyes?
Brid Morris et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration
Anne E. Fung et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Polypoidal choroidal vasculopathy in elderly Chinese patients
F Wen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Polypoidal choroidal vasculopathy
AP Ciardella et al.
SURVEY OF OPHTHALMOLOGY (2004)